Federal HB3037 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal HB3037, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. These examinations include diagnostic mammography, breast magnetic resonance imaging, and breast ultrasound. The bill also modifies the Internal Revenue Code to ensure that high deductible health plans with health savings account eligibility are not disqualified for not having a deductible for these examinations.

Federal HB3037 prohibits cost-sharing for diagnostic and supplemental breast examinations.

Federal HB3037, the Access to Breast Cancer Diagnosis Act of 2025, amends the Public Health Service Act to prohibit group health plans and health insurance issuers from imposing cost-sharing requirements for diagnostic and supplemental breast examinations. These examinations include diagnostic mammography, breast magnetic resonance imaging, and breast ultrasound. The bill also modifies the Internal Revenue Code to ensure that high deductible health plans with health savings account eligibility are not disqualified for not having a deductible for these examinations.